232 related articles for article (PubMed ID: 17137090)
1. [The cost per year of life gained: trends and internal contradictions].
Smulders YM; Thijs A
Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2467-70. PubMed ID: 17137090
[TBL] [Abstract][Full Text] [Related]
2. [The cost per year of life gained: trends and internal contradictions].
van Dam J
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):441; author reply 441-2. PubMed ID: 17343145
[No Abstract] [Full Text] [Related]
3. [The cost per year of life gained: trends and internal contradictions].
van Dam J
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):895; author reply 895. PubMed ID: 17472124
[No Abstract] [Full Text] [Related]
4. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
5. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
[TBL] [Abstract][Full Text] [Related]
6. [Economic examination of the 2006/7 update of the Israeli national list of health services].
Shmueli A; Nissan-Englcin E
Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
[TBL] [Abstract][Full Text] [Related]
7. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of sevelamer in patients with end-stage renal disease.
Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
[TBL] [Abstract][Full Text] [Related]
9. [Incremental cost effectiveness of multifocal cataract surgery].
Pagel N; Dick HB; Krummenauer F
Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
[TBL] [Abstract][Full Text] [Related]
10. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
11. Money for health: the equivalent variation of cardiovascular diseases.
Groot W; Van Den Brink HM; Plug E
Health Econ; 2004 Sep; 13(9):859-72. PubMed ID: 15362178
[TBL] [Abstract][Full Text] [Related]
12. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
13. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
Neubauer AS; Holz FG; Schrader W; Back EI; Kühn T; Hirneiss C; Kampik A
Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
[TBL] [Abstract][Full Text] [Related]
14. Health care costs in the last year of life--the Dutch experience.
Polder JJ; Barendregt JJ; van Oers H
Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
[TBL] [Abstract][Full Text] [Related]
15. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.
Bemelmans W; van Baal P; Wendel-Vos W; Schuit J; Feskens E; Ament A; Hoogenveen R
Prev Med; 2008 Feb; 46(2):127-32. PubMed ID: 17822752
[TBL] [Abstract][Full Text] [Related]
16. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of neonatal surgery and subsequent treatment for congenital anorectal malformations.
Poley MJ; Stolk EA; Langemeijer RA; Molenaar JC; Busschbach JJ
J Pediatr Surg; 2001 Oct; 36(10):1471-8. PubMed ID: 11584391
[TBL] [Abstract][Full Text] [Related]
18. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.
van Baal PH; Feenstra TL; Hoogenveen RT; de Wit GA; Brouwer WB
Health Econ; 2007 Apr; 16(4):421-33. PubMed ID: 17039573
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
20. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
